ALTHOUGH the fine details of
the Fifth Community Pharmacy
Agreement won’t be released until
next week, it’s understood that
yesterday’s signing of the pact also
resolves the impasse over funding
of chemotherapy programs.
A 2008 budget measure which
proposed to change the way that
chemotherapy medications are
reimbursed under the PBS to a
dose-based system, has been on
hold for some time pending the
resolution of the Fifth Agreement.The above article was sent to subscribers in Pharmacy Daily's issue from 04 May 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 May 10
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.